Cintas (CTAS) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
7 Apr, 2026Executive summary
Third quarter revenue reached $2.84 billion, up 8.9% year-over-year, with organic growth of 8.2%.
Net income for the quarter was $502.5 million, up 8.4%, and diluted EPS increased 9.7% to $1.24.
Achieved record gross margin of 51% and strong operating margins across all route-based businesses.
Announced agreement to acquire UniFirst Corporation for $5.5 billion, expected to close in the second half of calendar 2026, pending regulatory and shareholder approval.
Returned $1.45 billion to shareholders via dividends and buybacks in the first nine months of fiscal 2026.
Financial highlights
Operating income for the quarter was $659.9 million (23.2% of revenue), up 8.2% year-over-year.
Gross margin for Q3 reached $1.45 billion, up 9.8% year-over-year; consolidated gross margin at 51%, up 40 basis points.
Effective tax rate for the quarter was 20.6%, slightly down from 21% a year ago.
Cash flow from operations for the nine months was $1.57 billion, with free cash flow at $1.27 billion.
Selling and administrative expenses were 27.8% of revenue, up 60 basis points due to a prior-year one-time gain.
Outlook and guidance
Fiscal 2026 revenue guidance raised to $11.21–$11.24 billion, representing 8.4%–8.7% growth.
Adjusted diluted EPS guidance increased to $4.86–$4.90, up 10.5%–11.4%.
Guidance assumes constant FX, no future acquisitions, and a 20% effective tax rate.
Transaction costs related to UniFirst expected to impact EPS by $0.03–$0.04 in fiscal 2026, to be broken out separately starting Q4.
Management expects continued sufficient liquidity and strong cash flows to support operations, acquisitions, share repurchases, and dividends.
Latest events from Cintas
- $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Record growth, margin expansion, and a four-for-one stock split highlight strong 2025 outlook.CTAS
Q4 20243 Feb 2026 - Revenue and profit surged, margins expanded, and guidance was raised for fiscal 2025.CTAS
Q1 202520 Jan 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026 - Revenue and net income surged with margin gains and higher full-year guidance.CTAS
Q2 202510 Jan 2026 - Record revenue, margin expansion, and raised guidance highlight strong quarterly performance.CTAS
Q2 20267 Jan 2026 - Q3 revenue and EPS surged, driving higher guidance and strong margin expansion.CTAS
Q3 20256 Jan 2026 - Directors, executive pay, and auditors approved; special meeting proposal rejected; growth plans highlighted.CTAS
AGM 202514 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and key ESG shareholder proposals.CTAS
Proxy Filing1 Dec 2025